The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.

CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a ...

Scientists are investigating whether a concentrated hop extract can trigger the gut’s “bitter brake,” a natural signaling pathway that may help reduce hunger and support appetite control.

Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...

Amylyx (AMLX) downgraded to Buy after AMX0035 PSP halt; focus shifts to avexitide Phase 3 with Q3 2026 data and strong cash ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

YCT-529 inhibits retinoic acid receptor alpha to suppress sperm production reversibly. Currently in Phase 1b/2a trials, the compound has shown promise in preclinical models and aims to expand ...

Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.

A shot that keeps a mare from getting pregnant sounds simple. In practice, it is one of the messier problems in wildlife management, where every extra dose means another chase, another dart, another ...

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the growing ...

India is home to nearly 90 million people with T2DM , with an estimated 39.4 million remaining undiagnosed. Recent estimates from India indicate that approximately 80% of individuals with T2DM ...

A wearable light therapy device tuned to near-infrared wavelengths has reduced a key cellular aging marker by 92% in laboratory tests on human hair follicle cells, according to new research. The ...